Search

everythinglearnresearchcommunity

for

Search:↓

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Early-onset hair loss is linked to Parkinson's disease and decreased fertility.

Male pattern baldness is a common type of hair loss in men.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Alopecia areata treatment varies, with no optimal method established yet.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Minoxidil treatment can reduce hair shedding, increase hair volume, and even change hair color in patients with loose anagen hair syndrome.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.

Minoxidil activation by hair enzymes predicts treatment success for female hair loss.

Tofacitinib may effectively treat folliculitis decalvans.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

Sublingual minoxidil safely promotes hair growth.

Iron influences root hair growth during phosphate starvation by affecting auxin distribution and vesicle trafficking.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.